Is Reducing Down Syndrome Births a Form of Eugenics?
By Richard Gunderman,
Psychology Today
| 01. 03. 2021
A recently released study finds that Europe has reduced the number of babies born with Down syndrome by 54%. In 2016, the same researchers found that the U.S. rate of Down syndrome births had declined by 33%. Some friends and colleagues have asked me whether such reductions, which entail prenatal diagnosis and elective pregnancy termination, mean that we are still practicing some form of eugenics.
Down syndrome is a genetic disorder usually associated with an extra copy of chromosome 21 – hence its other name, trisomy 21. Children with Down syndrome generally exhibit growth delays, reduced intelligence, and a shortened life span of around 60 years. The risk of having a baby with Down syndrome increases with parental age. When prenatal testing reveals the diagnosis, some parents, including apparently many in Europe and the US, elect to terminate the pregnancy.
The widely-shared belief that people with Down syndrome cannot have children is mistaken. Fertility rates across the board for individuals with Down syndrome are lower – and much lower in men than in women – but babies have been...
Related Articles
By Rachel Hall, The Guardian | 11.20.2025
Couples are needlessly going through IVF because male infertility is under-researched, with the NHS too often failing to diagnose treatable causes, leading experts have said.
Poor understanding among GPs and a lack of specialists and NHS testing means male infertility...
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
By Pam Belluck and Carl Zimmer, The New York Times | 11.19.2025
Gene-editing therapies offer great hope for treating rare diseases, but they face big hurdles: the tremendous time and resources involved in devising a treatment that might only apply to a small number of patients.
A study published on Wednesday...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...